| Lorraine E Katz, MD | |
|
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Endocrinology, Philadelphia, PA 19104-4319 | |
| (215) 590-3174 | |
| (215) 590-3053 |
| Full Name | Lorraine E Katz |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 3401 Civic Center Blvd, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003830027 | NPI | - | NPPES |
| 6941401 | Medicaid | NJ | |
| 0015843800001 | Medicaid | PA | |
| 0015843800003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 25MA06345600 (New Jersey) | Secondary |
| 2080P0205X | Pediatrics - Pediatric Endocrinology | MD047032L (Pennsylvania) | Primary |
| Entity Name | Children's Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427152917 PECOS PAC ID: 1052219110 Enrollment ID: O20031229000053 |
News Archive
A study among Baltimore inner-city teenage girls treated for pelvic inflammatory disease shows they are highly vulnerable to subsequent sexually transmitted infections (STI) - sometimes within a few weeks or months of their treatment.
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy anastrozole, indicating that the drug may be an effective new option for breast cancer prevention for this group of women, according to initial results of a double-blind, randomized, placebo-controlled trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14. The study is being simultaneously published in the The Lancet.
The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when used with Norvir (ritonavir), another HIV antiviral medication.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lorraine E Katz, MD 100 E Penn Sq, Wanamaker Building 9th Flr, Philadelphia, PA 19107-3323 Ph: (267) 425-9234 | Lorraine E Katz, MD 3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Endocrinology, Philadelphia, PA 19104-4319 Ph: (215) 590-3174 |
News Archive
A study among Baltimore inner-city teenage girls treated for pelvic inflammatory disease shows they are highly vulnerable to subsequent sexually transmitted infections (STI) - sometimes within a few weeks or months of their treatment.
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
Breast cancer incidence among postmenopausal women at high risk for developing the disease was significantly reduced by the antihormone therapy anastrozole, indicating that the drug may be an effective new option for breast cancer prevention for this group of women, according to initial results of a double-blind, randomized, placebo-controlled trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14. The study is being simultaneously published in the The Lancet.
The U.S. Food and Drug Administration today announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir), describing potentially life-threatening side effects on the heart when used with Norvir (ritonavir), another HIV antiviral medication.
› Verified 6 days ago
Aaron Dorfman, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Cardiology, Philadelphia, PA 19104 Phone: 215-590-4040 Fax: 267-425-9800 | |
Brian Lestini, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 34th & Civic Center Blvd, Children's Hospital Of Philadelphia, Philadelphia, PA 19104 Phone: 215-590-1000 Fax: 215-590-2204 | |
Elizabeth Foglia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3400 Spruce St, 8 Ravdin, Philadelphia, PA 19104 Phone: 215-662-3228 Fax: 215-349-8831 | |
Dr. Katharine Taylor Levinson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 34th St And Civic Ctr Blvd, Philadelphia, PA 19104 Phone: 215-590-1000 Fax: 215-481-8795 | |
Ms. Amman Hassan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5501 Old York Rd, Philadelphia, PA 19141 Phone: 215-456-3810 | |
Dr. Geoffrey Libarnes Bajwa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 160 E Erie Ave, Philadelphia, PA 19134 Phone: 215-427-5000 | |
Helen Marie Stanley, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3401 Civic Center Blvd Rm 55, Philadelphia, PA 19104 Phone: 215-590-1220 |